Home TRAD Events Doctors Decide Project Sign me up
Overview Global Vision VTE and Cancer News The Team Projects Publications Partners & Funders Patient Stories
Home

Join our Newsletter

Name

Email (required)

TRAD Alliance Membership


Anticoagulation Length in Cancer Associated Thrombosis (ALICAT)

alicat_0.2.pub

A feasibility study to inform the design of a randomised controlled trial to identify the most clinically and cost effective length of anticoagulation with low molecular weight heparin in the treatment of cancer associated thrombosis (CAT). CI: Dr Simon Noble, Aneurin Bevan. Funder: Health Technology Assessment.



 Patient Experience of LIving with CANcer associated thrombosis (Pelican)


PELICAN posterv04 141013 st.pubCAT is now recognised as a separate disease that should be managed differently to VTE in patients without cancer. Whilst the management of CAT is clearly well known, the effect of CAT on the patient’s quality of life (QoL) is yet to be properly measured. CAT is a world-wide problem, not related to just one particular country. The aim of the study is to evaluate the experiences of patients with CAT in the UK in order to have an understanding of the impact of CAT and to find ways to improve their QoL.



The Primary Thromboprophylaxis Project (PTP)


This study aims to investigate the relationship between risk of VTE and development of symptoms.

Seven UK hospices contributed anonymised case-note data collected during an evaluation of systematic implementation of a VTE risk assessment protocol using the Pan Birmingham Cancer Network palliative-modified Thromboembolic Risk Factors (THRIFT) Concensus Group criteria, and presence/absence of a temporary elevated risk (TER) of VTE. This arose from an audit of the effect of risk assessment on low molecular weight thromboprophylaxis prescribing.

Symptoms/signs during admission consistent with possible VTE were documented. Data from 1164 consecutive admissions have now been analysed and the results report submitted for publication. Preliminary data has been reported in poster format at the 7th World Research Congress of the European Association for Palliative Care. Grateful thanks to the contributing centres.


 

Doctors Decide Project (DDP)


Doctors Decide ProjectDoctor's Decide Project Logo This study explores the factors that influence doctors when they decide how best to treat a patient who has both advanced cancer and VTE.

For more information on Doctors Decide Project select the Tab above or click here.

Mail: TRADAlliance@cardiff.ac.uk